Medigene AG (MDGEF)
OTCMKTS · Delayed Price · Currency is USD
2.590
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Medigene AG Market Cap
Medigene AG has a market cap or net worth of $699.6 thousand as of February 12, 2026. Its market cap has decreased by -97.36% in one year.
Market Cap
699.60K
Enterprise Value
-12.92M
Revenue
7.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.59
Market Cap Chart
Since June 30, 2000, Medigene AG's market cap has decreased from 438.84M to 699.60K, a decrease of -99.84%. That is a compound annual growth rate of -22.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 699.60K | 95.82% |
| Dec 30, 2025 | 357.26K | -97.70% |
| Dec 30, 2024 | 15.57M | -63.71% |
| Dec 29, 2023 | 42.90M | -20.29% |
| Dec 30, 2022 | 53.81M | -33.05% |
| Dec 30, 2021 | 80.37M | -24.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aibotics | 896.82K |
| Lipella Pharmaceuticals | 855.32K |
| EV Biologics | 840.53K |
| Protagenic Therapeutics | 766.63K |
| SQZ Biotechnologies Company | 707.79K |
| Sorrento Therapeutics | 706.83K |
| Hepion Pharmaceuticals | 662.36K |
| Avenue Therapeutics | 631.21K |